BREAKING NEWS: Pfizer’s COVID-19 vaccine offers 97% protection and it shows 94% effectiveness against asymptomatic infections, Israel study finds
- Pfizer Inc and BioNTech SE’s coronavirus vaccine prevented 97% of symptomatic cases, hospitalizations and deaths
- It was also 94% effective at blocking asymptomatic cases of infection
- The results were announced by the health ministry in Israel, which has led the world in pandemic vaccination
Pfizer Inc and BioNTech SE’s coronavirus vaccine is effective at blocking both symptomatic and asymptomatic cases of infection, a new study finds.
The Israeli Ministry of Health said on Thursday revealed on Thursday that the COVID-19 was 97 perfect effective at preventing symptomatic cases, hospitalizations and deaths.
What’s more, the jab was 94 percent effective at preventing cases that didn’t involve classic symptoms such as a cough, fever or shortness of breath.
‘This clearly demonstrates the power of the Covid-19 vaccine to fight this virus,’ Yeheskel Levy, director of the health ministry, said in a statement.
‘We aim to achieve even higher uptake in people of all ages, which gives us hope of regaining normal economic and social function in the not-so-distant future.’
Pfizer Inc and its German partner BioNTech are studying a third dose of their coronavirus vaccine, which is aimed at protecting against future variants. Pictured: A health worker shows a vial of the Pfizer-BioNTech COVID-1) vaccine, in San Jose, Costa Rica, February 24
This is a breaking news story and will be updated.